Order Desirial® for Clinics

Desirial® is a hyaluronic acid injectable gel formulated for professional use in vulvovaginal and intimate aesthetic care. Licensed clinics and healthcare professionals can order Desirial for treatment-room workflows that require sterile, pre-filled syringes, lot tracking, and protocol-based administration. The line includes a baseline hydration-focused profile and Desirial Plus, a 21 mg/ml option used when greater structural support is clinically appropriate.

Clinics use Desirial hyaluronic acid gel within gynecology, intimate wellness, and aesthetic programs where mucosal hydration, tissue suppleness, or labia majora contour support is part of the care plan. Administration should be performed only by trained practitioners following the manufacturer’s instructions, local standards, and the supervising clinician’s assessment.

Desirial Price, Variant Selection, and Clinic Ordering

Sign in to view current Desirial price information and available clinic purchasing tiers. Public unit pricing is not published because quotes can depend on variant, lot availability, order quantity, and contract terms. Your account team can support recurring procurement, multi-location planning, and shipment timing for scheduled procedure blocks.

When selecting product, match the variant to the intended tissue goal and institutional protocol. The standard Desirial profile is positioned for intimate mucosal hydration and elasticity support. Desirial Plus is commonly selected when additional projection or soft-tissue reinforcement is needed, and the supplied product information identifies the Plus configuration at 21 mg/ml.

Access requires a verified clinical account. Orders are processed for professional use by licensed clinics and healthcare professionals, with product documentation that supports intake, inventory rotation, and procedure records. For teams building a broader intimate-care program, the Gynecology category can help staff review adjacent professional products used in similar workflows.

What Desirial Is and How It Works

Desirial is an injectable hyaluronic acid gel designed for delicate vulvovaginal tissue planes. Hyaluronic acid is a water-binding polysaccharide used in many medical and aesthetic gels because it helps retain moisture and supports tissue suppleness. In this product line, the gel is antioxidant-stabilized and crosslinked to provide cohesive behavior during placement.

The product is supplied in sterile, single-use pre-filled syringes for controlled setup in a clinical environment. That format supports consistent preparation, clear lot and expiry recording, and efficient disposal after the procedure. Keep the syringe sealed in its original packaging until setup to protect sterility and preserve identifying information.

Desirial should not be treated like a general facial filler or a consumer intimate-care product. The injection site, tissue depth, and patient selection requirements differ from routine facial correction. Clinics should ensure that practitioners are credentialed for intimate injection techniques and that informed consent, pre-procedure evaluation, and post-procedure instructions align with internal policy.

Professional Applications in Gynecology and Aesthetic Care

Gynecology teams may incorporate Desirial into care pathways for urogenital dryness, mild atrophic changes, and comfort-focused intimate care when the supervising clinician determines that an injectable HA approach fits the patient’s assessment. Aesthetic practices may use the line in protocols focused on subtle labia majora contour, hydration support, or soft-tissue quality in the external intimate area.

Desirial Plus is often considered when volume loss or reduced labia majora projection is the main procedural goal. The choice between Desirial and Desirial Plus should be based on tissue findings, symptom profile, desired structural effect, and the manufacturer’s technique guidance. Clinics that offer both intimate and conventional injectable services can also review the broader Dermal Fillers category for class context and related professional supplies.

Operator technique matters because intimate tissues are sensitive and highly vascular. Many clinics prefer microcannula approaches for subdermal fan or linear threading in the labia majora, while small-gauge needles may be used for localized mucosal hydration according to local protocols. Staff should document the product used, lot number, injection area, device choice, volume placed, and any immediate observations after treatment.

Desirial vs Desirial Plus

Desirial and Desirial Plus belong to the same intimate HA portfolio, but they are used for different procedural goals. The baseline Desirial profile is typically aligned with hydration and elasticity support in vulvovaginal mucosal care. Desirial Plus provides a more structural option for cases where soft-tissue volume is notably reduced.

Clinics that routinely stock both variants can tailor treatment-room inventory without relying on unrelated HA products for intimate indications. For a dedicated Plus configuration, review Desirial Plus 21 mg/ml pre-filled syringe details before procurement.

Key Features for Clinic Workflow

• Hyaluronic acid gel formulated for intimate mucosa and delicate tissue planes.
• Antioxidant-stabilized network designed to support residence in a high-movement area.
• Crosslinked structure that provides cohesive handling during controlled placement.
• Sterile, pre-filled, single-use syringe format for treatment-room efficiency.
• Visible lot and expiry details that support stock rotation and procedure records.
• Baseline and Plus profiles to match hydration-focused or structural goals.
• Smooth extrusion characteristics intended to aid steady operator control.
• Professional-use positioning for trained clinicians in gynecology and aesthetics.

Quick tip: Record the variant, lot number, expiry, injection area, and device choice immediately after each procedure.

Packaging, Storage, and Handling

Desirial units arrive as sterile pre-filled syringes sealed for single use. Store products in their original cartons according to the package insert and your facility’s medical product handling procedures. Do not use a unit if the sterile barrier is damaged, the labeling is unclear, or the expiration date has passed.

Intake staff should inspect cartons on receipt, record lot and expiry details, and rotate inventory so the earliest dated stock is used first. Keep units segregated by variant to reduce selection errors during setup. Treatment rooms should have sharps disposal, aseptic preparation supplies, and any clinic-approved adjuncts ready before the syringe is opened.

Orders may be supported by temperature-controlled handling when required and tracked US delivery. Receiving teams should plan for business-hours acceptance and secure storage after arrival. If product handling instructions differ from routine room-temperature inventory practices, follow the carton label and package insert over general clinic habits.

Safety, Contraindication Checks, and Documentation

Desirial should be used only after an appropriate clinical assessment. Practitioners should screen for factors that could affect injection safety, including active local infection, inflammation at the intended site, known hypersensitivity to product components, relevant bleeding risk, pregnancy or postpartum considerations when applicable to local policy, and prior procedures in the same anatomical area. The package insert supplied with each unit remains the controlling source for contraindications, warnings, and technique requirements.

Expected local reactions after HA injection can include tenderness, swelling, bruising, redness, or temporary discomfort at the treatment site. Clinics should counsel patients on expected aftercare, signs that require medical contact, and the importance of follow-up when symptoms are persistent, worsening, or unusual. Serious vascular, infectious, inflammatory, or allergic events are uncommon but require prompt clinician assessment if suspected.

Documentation supports both safety and inventory accountability. Procedure notes should capture the assessment rationale, consent, product variant, lot number, expiry, injection method, anatomical area, volume used, immediate response, and aftercare instructions. Staff training should also cover adverse-event escalation, product traceability, and cleaning protocols for intimate treatment areas.

Composition and Mechanism

The active component is crosslinked hyaluronic acid formulated for intimate tissue planes. Hyaluronic acid binds water, which helps maintain hydration and tissue suppleness. The crosslinked gel network gives the preparation greater persistence than non-crosslinked topical HA products and supports controlled placement by trained injectors.

An antioxidant stabilizer is included to help protect the gel environment during residence in tissue. The specific qualitative composition can vary by variant, so clinics should consult the package insert and carton labeling supplied with each unit. Concentration and rheology should guide protocol selection alongside the patient’s tissue status and the clinician’s objective.

Clinics comparing HA families should avoid assuming that facial filler behavior translates directly to intimate care. Tissue mobility, mucosal sensitivity, vascular considerations, and patient comfort requirements differ. For additional professional discussion of this treatment area, see intimate HA injection technique and care considerations.

Comparable Products and Related Choices

Desirial is best evaluated as an intimate HA product rather than a general-purpose aesthetic filler. Clinics should select it when the procedure involves vulvovaginal hydration support, intimate tissue elasticity, or labia majora contour planning within a trained provider’s scope. Conventional facial HA fillers may have different rheology, injection depths, and labeling expectations.

For practices expanding beyond intimate care, the Dermal Fillers education category can support staff discussions about HA gel classes, rheology, and aesthetic treatment planning. Use those materials for professional context only; device selection, injection depth, and product choice should remain protocol-specific.

When substituting within the intimate HA category, confirm compatibility with clinic procedures before scheduling treatment. A substitute should match the intended anatomical area, gel behavior, documentation requirements, and practitioner training. If a preferred variant is temporarily constrained, your account manager can help identify class-appropriate alternatives without changing the clinician’s responsibility to approve the protocol.

Inventory Planning for Licensed Clinics

Clinics that schedule intimate injectable treatments in blocks should plan inventory around consultation volume, expected variant mix, and staff credentialing. Keeping the standard profile and the Plus profile separate in storage reduces setup errors and helps team members select the correct syringe for each procedure plan. Carton-level labels should remain visible until the product is prepared for use.

Recurring procurement can help align product supply with upcoming procedure days. Multi-location practices should centralize lot tracking standards so each facility records the same information. If one site transfers stock internally, preserve original packaging and retain the chain of documentation required by your policy.

Why it matters: Intimate injectable procedures rely on traceable sterile products, trained operators, and clear records.

Authoritative Sources

• Manufacturer product literature and package inserts supplied with each Desirial unit.
• Professional society statements and local clinical standards covering hyaluronic acid use in intimate tissues.
• Internal clinical protocols approved by the supervising practitioner or medical director.

Sign in to confirm current stock, finalize quantities, and coordinate professional-use ordering for your facility.

This content is for informational purposes only and is not a substitute for professional medical advice.